Palvella Secures Patent Protection Ahead of Rare Skin Trial
WAYNE, PA — Palvella Therapeutics (Nasdaq: PVLA) has secured a new U.S. patent covering a key treatment approach for porokeratosis, strengthening its intellectual property position as the company prepares to …
Palvella Secures Patent Protection Ahead of Rare Skin Trial Read More